[HTML][HTML] Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives
VK Panthi, KE Fairfull-Smith, N Islam - International Journal of …, 2024 - Elsevier
Typical antibiotic treatments are often ineffectual against biofilm-related infections since
bacteria residing within biofilms have developed various mechanisms to resist antibiotics. To …
bacteria residing within biofilms have developed various mechanisms to resist antibiotics. To …
[HTML][HTML] Liposome drug delivery in combating the widespread topical antibiotic resistance: a narrative review
LD Rizkita, RGP Putri, M Farid… - … Journal of Basic …, 2024 - bjbas.springeropen.com
The increasing trend of antibiotic resistance has posed challenges for scientists, especially
in developing better drug formulations. The discovery of new antibiotics could take years …
in developing better drug formulations. The discovery of new antibiotics could take years …
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Introduction Angiotensin-converting enzyme 2 (ACE2) and AXL tyrosine kinase receptor are
known to be involved in the SARS-CoV-2 entry of the host cell. Therefore, targeting ACE2 …
known to be involved in the SARS-CoV-2 entry of the host cell. Therefore, targeting ACE2 …